Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax
about
Bacillus anthracis edema factor substrate specificity: evidence for new modes of actionA New Murine Model for Gastrointestinal Anthrax InfectionBacillus anthracis has two independent bottlenecks that are dependent on the portal of entry in an intranasal model of inhalational infection.In trans complementation of lethal factor reveal roles in colonization and dissemination in a murine mouse model.Circulating lethal toxin decreases the ability of neutrophils to respond to Bacillus anthracis.Lethal factor, but not edema factor, is required to cause fatal anthrax in cynomolgus macaques after pulmonary spore challengeAnthrax lethal toxin-induced lung injury and treatment by activating MK2.Identification of novel host-targeted compounds that protect from anthrax lethal toxin-induced cell death.Bacillus anthracis co-opts nitric oxide and host serum albumin for pathogenicity in hypoxic conditions.Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational AnthraxToxin-independent virulence of Bacillus anthracis in rabbits.Modulation of the Bacillus anthracis secretome by the immune inhibitor A1 protease.Bacillus anthracis spore movement does not require a carrier cell and is not affected by lethal toxin in human lung modelsA Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis.Nitric oxide production contributes to Bacillus anthracis edema toxin-associated arterial hypotension and lethality: ex vivo and in vivo studies in the rat.Using Telemetry Data to Refine Endpoints for New Zealand White Rabbits Challenged with Bacillus anthracis.Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen.
P2860
Q27000357-2E9BE0EB-C0B6-4B32-AC69-80E9768B41C5Q27313379-97F96F2B-27FD-4C32-AAF8-558523A3A5D9Q30412775-B21D95C9-77BD-4E14-85DF-64716AC0AFCEQ30413638-C5EDB8B6-9AEC-4901-9FE7-E65A3CE12BD3Q30457081-54289DE0-BFF4-4610-8CAC-9EDE4E2A7834Q34647017-0C27A05C-230D-4316-BCB8-216267F83578Q35960060-AD342884-4CA8-43DA-80C2-3F91F867E4CEQ36802132-7EAC3483-E2AB-4F4F-859A-58C3A553246FQ36850520-BF613CFE-404A-4E7F-A3E4-F6D0956C5EECQ37287801-98B632B1-AA92-4D24-9434-CD358C2618CAQ37453046-05512527-79AF-4910-98CE-79412CD31742Q37545907-977E1DA8-5847-43A5-9E86-7A30F14F7561Q38763425-ECB0DB0B-084D-4A98-A0FF-1E5C217B5E0CQ40140655-6CEB0D71-26C8-40E4-8221-76F6157469ECQ40603158-0C97A953-33D3-4451-A967-985377745BABQ47284551-17BF9607-63C0-4B3C-A635-540E13E255A8Q49444286-D896D389-259D-43E0-A493-B5C0DC2E9692
P2860
Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Expression of either lethal to ...... model of inhalational anthrax
@ast
Expression of either lethal to ...... model of inhalational anthrax
@en
type
label
Expression of either lethal to ...... model of inhalational anthrax
@ast
Expression of either lethal to ...... model of inhalational anthrax
@en
prefLabel
Expression of either lethal to ...... model of inhalational anthrax
@ast
Expression of either lethal to ...... model of inhalational anthrax
@en
P2093
P2860
P356
P1476
Expression of either lethal to ...... model of inhalational anthrax
@en
P2093
C Rick Lyons
Julie A Hutt
Julie A Lovchik
Melissa Drysdale
Theresa M Koehler
P2860
P304
P356
10.1128/IAI.06340-11
P407
P577
2012-04-23T00:00:00Z